Objective: To report a case of extramedullary plasmacytoma, a rare localized tumour involving the head and neck region in a 56-year -old gentleman.
1
. Three clinical manifestations exist: solitary, aggressive and disseminated. It is a rare neoplastic lesion that may occur in the head and neck region. 1 These lesions account for 4% of all nonepithelial tumors of the nasal cavity, paranasal sinuses and nasopharynx and they represent 0.4% of all head and neck malignancies. 1 They have a slight predilection to men with peak incidence in patients aged 50 to 60 years. 2 Extramedullary plasmacytoma can occur synchronously with multiple myeloma or can be antecedent to multiple myeloma years after, hence, the role of comprehensive multidisciplinary approach in long term management of such patients. The interrelationship between these different neoplastic plasma cell disorders was first described by Batsakis in 1983 . 3 The development of multiple myeloma has been observed in 8 to 36% of patients with extramedullary plasmacytoma. 1, 2 Whilst plasmacytomas tend to be discrete and solitary, multiple myeloma is diagnosed when there is diffuse infiltration of the marrow with neoplastic plasma cells.
CASE REPORT
A 56-year-old gentleman with multiple co-morbidities presented to us in April 2003 with a 5-month history of right sided progressively worsening nasal blockage associated with intermittent self limiting epistaxis. This was associated with anosmia and occasional right sided temporal headaches. There was no history of loosening of teeth, facial swelling, diplopia or blurring of vision. Examination revealed a friable, dark red mass arising from the roof of the nasopharynx, completely occluding the right choana ( Figure 1) . Intraorally, there was inferior extension of the mass to the soft palate. There was no palpable cervical lymphadenopathy and cranial nerve examination was unremarkable. No other lesions were found in the head and neck region. He had a background history of hypertension, ischaemic heart disease and was an ex-chronic smoker.
Computed tomography showed a heterogeneously enhancing soft tissue density mass measuring 2.5 cm in its largest dimension, arising from the right post nasal space. No associated bony erosion or cervical lymphadenopathy was present. Biopsy of the mass revealed a nodular grayish tissue microscopically showing diffuse infiltration of the submucosal layer with plasma cells. The plasma cells were mature in appearance with eccentric nuclei and clock face chromatin pattern. Immunohistochemical studies revealed strong positivity towards lambda restriction and were negative for kappa, LCA, B and T cell markers as well as cytokeratin. A histopathological diagnosis of extramedullary plasmacytoma of the nasopharynx was entertained. Urine and plasma electrophoresis were performed following this histological diagnosis, revealing no evidence of monoclonal band. Bone scan of the paranasal sinuses and skeletal surveys showed no lytic bony lesions suggestive of multiple myeloma. He underwent bone marrow and trephine biopsy to rule out marrow involvement. However, he developed cardiogenic shock secondary to unstable angina immediately following the procedure necessitating resuscitation and inotropic support. The bone marrow and trephine biopsy showed only occasional abnormal plasma cells of less than 5%. He recovered from the cardiac event and was offered curative radiotherapy in view of his poor general medical condition. He subsequently underwent curative radiotherapy of 50 Gy for a total of 23 fractions to the nasopharynx.
He was well post radiotherapy with no further episodes of epistaxis or nasal obstruction. Total resolution of the mass was observed following radiotherapy with no subsequent evidence of local recurrence. Figure 4 shows an endoscopic view of the right choana 7 years post irradiation. This patient is receiving surveillance follow up from both the otorhinolaryngology and hematology teams. Up till his last visit at 7 years post irradiation, surveillance endoscopy, urine and serum paraprotein showed no significant evidence of local recurrence or development to multiple myeloma. 
DISCUSSION
Plasma cell neoplastic disorders are important for otorhinolaryngologists to recognize since according to Wiltshaw in 1976, 80% of extramedullary plasmacytomas occur in the head and neck and 10-20% of cases may present with multiple lesions. 6 The etiology of extramedullary plasmacytoma is unknown. Proposed risk factors include chronic antigenic stimulation such as osteomyelitis, cholecystitis, rheumatoid arthritis and bacterial flora. Plasmacytoma formation has been demonstrated in laboratory mice treated with salmonella flagellar antigen and with bovine serum albumin. Genetic factors, radiation exposure, smoking and occupational exposures have also been implicated in the myeloma literature as possible etiologic agents. 3, 7, 8 Wax, et al. in 1993 reviewed similar cases and found that 75% of extramedullary plasmacytomas occurred in the sinonasal or nasopharyngeal area, 12% in the oropharynx, 8% in the larynx, and other sites in the head and neck including the tongue, minor salivary glands, thyroid, parotid, orbit and temporal bone. 10 Outside of the head and neck, extramedullary plasmacytoma has been reported in the pleura, mediastinum, spermatic cord, ovary, intestines, kidney, pancreas, breast, and skin. 10 Most of the symptoms related to extramedullary plasmacytoma can be related to their specific location in the head and neck. Cervical lymph node metastasis is reported to occur in 12-26% of cases at initial presentation.
Biopsy of the lesion is the first step in confirming the diagnosis. Deep biopsies must be taken since the tumor is submucosal and the mucosa may be thickened from an inflammatory reaction. 1 Histological subtypes of plasmacytoma including plasmacytic, plasmablastic and anaplastic subtypes have been described. However, these subtypes are neither indicative of prognosis or increased risk of recurrence.
1,3 Local amyloid deposits have been found in 11-38% of cases but systemic amyloidosis is very rare. Similar to multiple myeloma and other B cell neoplasms, a monoclonal staining pattern demonstrating either one heavy chain class, one light chain type or both can be demonstrated from immunohistochemical techniques. 3, 7, 8 With new advances in immunophenotyping, CD 138 has been recognized as a marker for neoplastic plasma cells. 17 However, it was not available in our centre at the point of diagnosis. Our immunohistochemical staining showed strong positivity to lambda restriction.
In a 1988 review of plasma cell disorders, Abemayor, et al. recommend a complete blood count with white blood cell count and platelet count, bone marrow biopsy, serum biochemistry including calcium, blood urea nitrogen, creatinine, uric acid, serum protein, serum and urine electophoresis, and a skeletal survey to rule out multiple myeloma. 7 Galieni et al. suggested certain diagnostic criteria for solitary extramedullary plasmocytoma. They include biopsy of tissue showing monoclonal plasma cell histology, bone marrow plasma cell infiltration showing less than 5% of all nucleated cells, absence of any osteolytic bone lesion, absence of hypercalcemia or renal failure and low levels of paraprotein concentration if present. 12 Our case satisfied all the criteria described above. High levels of paraprotein in the serum or urine should raise the clinician's suspicion of a disseminated process, since paraprotein levels correlate directly with tumor burden.
A review of therapeutic approaches to extramedullary plasmacytoma of the nasopharynx in published reports in the past ten years is discussed. Although similar cases have been described as early as 40 years ago, treatment has remained controversial. They include curative radiotherapy, curative surgical resection, salvage surgery and chemotherapy. 13 While it is agreed that extramedullary plasmacytomas are radiosensistive, there is no consensus in the literature about the ideal dose of radiation therapy. Residual tumor is observed in 20% of patients after radiotherapy, so additional courses are sometimes necessary. 14 Alexiou et al. suggested that surgery alone gave the best results for extramedullary plasmacytoma of the upper aero-digestive tract when resectability is good. However, if complete surgical resection was not possible or doubtful, and/or lymph nodes were affected, then combined therapy (surgery and radiation) was recommended. 15 There are very few reports of local recurrence of plasmacytomas treated primarily by surgery. 16 Most authors recommended salvage surgery if there is local failure following additional courses of radiotherapy. Salvage surgery following radiotherapy often yields more amyloid component rather than tumour tissue, suggesting its radiosensitive properties. 11 Rubin et al. in 1990 reviewed 14 series and 219 cases of extramedullary plasmacytoma of the head and neck in the literature. They found that 55% of patients treated with radiotherapy alone and 54% of patients treated with surgery alone had no evidence of recurrence post treatment. Mortality and recurrence were also noted to not be significantly different between the two groups. Chemotherapy and bone marrow transplantation is reserved for disseminated disease or progression to multiple myeloma. 9 Factors associated with poor prognosis in the literature include the presence of bone destruction, large primary tumor, recurrence, and tumors located in the sphenoid, maxillary sinus, orbit, and larynx. 6 Histologic appearance and lymph node involvement are not reported to be of any prognostic significance. Because extramedullary plasmacytoma can recur as disseminated multiple myeloma long term follow-up likewise in our patient is important. Cases of recurrence have been reported 28 and 36 years after initial treatment in the literature. 6 While most diseases are considered treated following five years of being recurrence free, such is not the case in plasmacytoma. Therefore, we plan for lifetime follow up in this patient, diligently anticipating any possible recurrence or progression to multiple myeloma.
Extramedullary plasmacytoma of the nasopharynx represents a tumour with good prognosis but requires long term follow up in anticipation of local recurrence and progression to multiple myeloma. 
